Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Below conscensus again

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Sep 26, 2023 12:08pm

118 Views

Post# 35654723

RE:RE:RE:Below conscensus again

A player like Knight Pharmaceutical would do a good eeal by acquiring Thera in a cash or share deal. They could use the acrrued losses also. I surveyed like 5% of the float ans 8$ cdn is the conscensus for a takover to proceed. I agree.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec